Tandem Diabetes Care, Inc.
Key Metrics
- Previous Close
- $17.06
- 52-Week Range
- $12.26 – $29.65
- Market Cap
- $1.19B
- P/E (TTM)
- —
- EPS (TTM)
- -0.70
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 8.80
- PEG Ratio
- —
- Return on Equity
- -36.73%
- Return on Assets
- -1.55%
- Gross Margin
- 56.65%
- Operating Margin
- -2.35%
- Profit Margin
- -4.58%
- Current Ratio
- 3.21
- Debt/Equity
- 5.45
- Total Debt
- $736.54M
- Free Cash Flow
- $-65.56M
- Revenue Growth
- 13.80%
- Earnings Growth
- —
- Enterprise Value
- $1.48B
Market Snapshot
About
Tandem Diabetes Care is a medical device company focused on developing and commercializing insulin delivery systems for people with diabetes. The company is best known for its t:slim X2 insulin pump with Control-IQ technology, which features automated insulin delivery and continuous glucose monitoring integration. Tandem offers innovative solutions designed to simplify diabetes management and improve patient outcomes.